Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

COSM

Cosmos Health Inc

Dec 01 • 04:00PM ET

1.13

Dollar change +0.09
Percentage change 8.65	%

Healthcare • Medical Distribution • Greece • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.22	Insider Own	13.05%	Shs Outstand	13.40M	Perf Week	3.67%
Market Cap	15.14M	Forward P/E	-	EPS next Y	-	Insider Trans	12.38%	Shs Float	11.65M	Perf Month	10.78%
Income	-42.91M	PEG	-	EPS next Q	-	Inst Own	5.57%	Short Float / Ratio	1.48% / 0.13	Perf Quarter	-4.24%
Sales	49.59M	P/S	0.31	EPS this Y	-	Inst Trans	-98.30%	Short Interest	0.17M	Perf Half Y	-67.34%
Book/sh	3.41	P/B	0.33	EPS next Y	-	ROA	-26.64%	Target Price	-	Perf Year	-92.40%
Cash/sh	0.18	P/C	6.36	EPS next 5Y	-	ROE	-64.96%	52W Range	0.97 - 23.84	Perf YTD	-75.22%
Dividend	-	P/FCF	-	EPS past 5Y	-22.04%	ROI	-88.17%	52W High	-95.26%	Beta	2.67
Dividend %	-	Quick Ratio	1.79	Sales past 5Y	12.24%	Gross Margin	7.27%	52W Low	16.49%	ATR	0.11
Employees	102	Current Ratio	2.06	Sales Q/Q	6.72%	Oper. Margin	-31.64%	RSI (14)	53.26	Volatility	12.74% 9.30%
Optionable	Yes	Debt/Eq	0.24	EPS Q/Q	86.15%	Profit Margin	-86.53%	Rel Volume	2.59	Prev Close	1.04
Shortable	Yes	LT Debt/Eq	0.09	Earnings	-	Payout	-	Avg Volume	1.33M	Price	1.13
Recom	-	SMA20	5.61%	SMA50	-6.07%	SMA200	-52.94%	Volume	3,287,677	Change	8.65%

Dec-01-23 10:25AM	Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product (ACCESSWIRE) +8.65%
Nov-21-23 09:00AM	Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/Share (ACCESSWIRE) -6.36%
Oct-11-23 09:35AM	Cosmos Health to Acquire Cloudscreen, a Cutting-Edge AI-Powered Drug Repurposing Platform; Anticipated to Establish Cosmos as a Leader in the $25Bn Global Market and Deliver Unparalleled Returns for Shareholders (ACCESSWIRE) +12.71%
Oct-05-23 08:30AM	COSMOS HEALTH CEO Issues Letter to Shareholders (ACCESSWIRE)
Sep-27-23 10:30AM	Cosmos Health Actively Exploring Spinoff of R&D Division into a Publicly Listed Standalone Biotech Company (ACCESSWIRE) -13.16%
11:00AM	Loading…
Sep-26-23 11:00AM	Cosmos Health Announces Expansion of Its C-Sept Brand with the Launch of C-Scrub Wash; Capitalizing on $29 Billion Global Antiseptic and Disinfectant Market (ACCESSWIRE) +9.83%
Sep-22-23 12:50PM	Cosmos Health Announces Relaunch of bio-bebe, its Proprietary Organic Infant Care & Nutrition Brand; Aims to Penetrate $103bn Global Baby Food Market (ACCESSWIRE)
Sep-20-23 11:50AM	Cosmos Health Announces Strategic Collaboration with C.A.PAPAELLINAS Group (ACCESSWIRE)
Sep-13-23 08:30AM	Cosmos Health Starts Stock Buyback Program (ACCESSWIRE)
08:00AM	BestGrowthStocks.com issues New Growth Report on Cosmos Health (News Direct)
Sep-12-23 08:30AM	Cosmos Health Introduces Guidance; Expects to Achieve Over $180M in Gross Annual Revenue and EBITDA in Excess of $20M by 2026; Recaps Significant Events Reported So Far in 2023 (ACCESSWIRE) +34.34%
Aug-15-23 07:00AM	Cosmos Health Reports Q2 2023 Financial Results; Adjusted Net Income Increases by 3550% to Surpass $3 Million for H1 2023 vs $(0.09) Million H1 2022; Book Value per Share Exceeds $4.04 (ACCESSWIRE)
Aug-08-23 09:20AM	Cosmos Health Appoints Big 4 Accounting Firm KPMG as Auditor (ACCESSWIRE)
Aug-02-23 01:15PM	Cosmos Health Continues to Expand Mediterranation Brand, Welcomes Eleonas and Olympus Mons; Boosts Exports and Secures Purchase Orders, Including from Leading Multinational Health Food Chain (ACCESSWIRE) -14.97%
Jul-25-23 09:25AM	Cosmos Health Provides Update on Recent Developments, Maintains Strong Financial Position, Reaffirms Commitment to Growth, and Highlights CEO's Continued Investment Now Exceeds $15 Million (ACCESSWIRE)
07:16AM	Loading…
07:16AM	Daily Vickers Top Buyers & Sellers for 07/25/2023 (Argus Research)
Jul-21-23 04:00PM	Cosmos Health Inc. Announces Closing of $5.25 Million Registered Direct Offering and Concurrent Private Placement (ACCESSWIRE)
Jul-20-23 08:00AM	Cosmos Health Inc. Announces Pricing of $5.25 Million Registered Direct Offering and Concurrent Private Placement (ACCESSWIRE) -23.39%
Jul-06-23 09:20AM	Cosmos Health Successfully Completes Acquisition of Cana Laboratories; Anticipates to Record a Substantial Gain on Bargain Purchase (ACCESSWIRE)
Jun-29-23 09:30AM	Cosmos Health Launches Chios Island, the Latest Addition to Its Mediterranation Premium Line of Supplements (ACCESSWIRE)
Jun-21-23 09:20AM	Cosmos Health Successfully Completes Second Phase of CCX0722 Development, an Innovative Product for Obesity and Weight Management: Significant Step in Bringing Product to the Multi-Billion-Dollar Market (ACCESSWIRE)
Jun-16-23 09:15AM	Cosmos Health Successfully Closes Acquisition of Assets from I. Bikas GP; Annual Revenue Projected to Grow by over $10 Million (ACCESSWIRE)
Jun-13-23 12:00PM	Cosmos Health Expands Premium Nutritional Supplements Line Mediterranation with the Launch of Terra Creta (ACCESSWIRE)
Jun-08-23 06:43AM	Daily Vickers Top Buyers & Sellers for 06/08/2023 (Argus Research)
May-31-23 09:15AM	Cosmos Health set to join Russell Microcap Index (ACCESSWIRE) +6.54%
May-25-23 11:00AM	Cosmos Health Enters into Binding Letter of Intent for the Acquisition of Docpharm GmbH., an Established German Pharmaceutical Distributor; Expected to Boost Our Annual Revenue by Approximately 32M, or 70%, by the End of 2025 vs FY 2022. (ACCESSWIRE)
May-17-23 08:00AM	Cosmos Health Reports First Quarter 2023 Financial Results; Delivers Positive Adjusted EBITDA and Significant Increase in Adjusted Net Income (ACCESSWIRE)
May-08-23 11:45AM	Cosmos Health Enters Final Phase for the Acquisition of Cana Laboratories Following Conclusion of Stock Purchase Agreement (ACCESSWIRE) +7.79%
May-03-23 01:35PM	Cosmos Health Advances Its Strategic Plan; Acquires Distressed Property Housing Operations of CosmoFarm, Expected to Generate Substantial Value for Shareholders (ACCESSWIRE)
May-01-23 06:45AM	Daily Vickers Top Buyers & Sellers for 05/01/2023 (Argus Research) -8.31%
07:00AM	Loading…
Apr-13-23 07:00AM	Cosmos Health Ends 2022 with Transformed Balance Sheet and Achieves Positive Adjusted EBITDA for the Fiscal Year 2022 (ACCESSWIRE)
Apr-05-23 09:50AM	Cosmos Health Inc. to Participate in The Economist Annual New York-Eastern Mediterranean Business Summit on July 10th, 2023, with CEO Mr. Greg Siokas Delivering a Speech (ACCESSWIRE) -5.83%
Apr-03-23 11:55AM	Cosmos Health Inc. Enters U.S. Telehealth Space with Successful Acquisition of ZipDoctor, Inc. (ACCESSWIRE)
Mar-24-23 10:35AM	Cosmos Health Inc.'s UK Subsidiary Decahedron Ltd. Named Pharmaceutical Wholesaler of the Month in the Latest Issue of Healthcare Matters (ACCESSWIRE)
Mar-17-23 01:45PM	Cosmos Health Inc. Enters into a Definitive Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp. (ACCESSWIRE) -6.49%
Mar-07-23 09:15AM	Cosmos Health Enters into a Material Definitive Agreement with Cana Laboratories (ACCESSWIRE) +15.06%
Mar-03-23 08:25AM	Cosmos Health Expects to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp. (ACCESSWIRE)
Feb-15-23 03:30PM	Cosmos Health Extends its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp. (ACCESSWIRE) +5.35%
Feb-07-23 09:15AM	Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests (ACCESSWIRE) -5.84%
08:30AM	Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM) (PR Newswire)
Feb-02-23 01:50PM	Cosmos Health Announces Application for Dual Listing on Upstream (ACCESSWIRE)
Feb-01-23 11:00AM	Cosmos Health Announces the Appointment of Nikos Bardakis, an Experienced Executive in the Pharmaceutical Industry, as Chief Operating Officer (ACCESSWIRE)
Jan-26-23 03:00PM	Cosmos Health Retains Christian Levine Law Group to Further Monitor Trading Irregularities (ACCESSWIRE)
Jan-24-23 12:40PM	Cosmos Health Announces Stock Buyback Program (ACCESSWIRE) +26.38%
Jan-20-23 01:40PM	Cosmos Health Extends and Updates its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp (ACCESSWIRE) +72.49%
Jan-17-23 09:15AM	Cosmos Health Provides an Update on its Debt Balance and Proforma Interest Expense (ACCESSWIRE) -5.73%
Jan-10-23 11:55AM	Cosmos Health Extends and Updates its Agreement to Acquire Cana Laboratories, a European Pharmaceutical Company (ACCESSWIRE) +5.69%
Jan-05-23 09:05AM	Cosmos Health Regains Nasdaq Minimum Bid Price Compliance (ACCESSWIRE) -7.20%
Dec-22-22 11:40AM	Cosmos Health CEO Participated in the Last Fundraising of the Company (ACCESSWIRE) -11.47%
Dec-21-22 04:10PM	Cosmos Health Inc. Announces Successful Closing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market (ACCESSWIRE) -8.45%
Dec-19-22 09:12AM	Cosmos Health Inc. Announces Pricing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market (ACCESSWIRE) -67.01%
Dec-15-22 07:45AM	Cosmos Holdings Inc. Changes its Name to Cosmos Health Inc. and Announces a 1-For-25 Reverse Stock Split (ACCESSWIRE)
Dec-09-22 11:30AM	Cosmos Health Retains Shareholder Intelligence Services, LLC (ACCESSWIRE)
Dec-02-22 03:10PM	Cosmos Health Provides a Summary Regarding Recent Share Activity and Reiterates its Belief and Commitment to the Financial Strength and the Growth and Profitability of the Company (ACCESSWIRE) +34.49%
Nov-29-22 05:10PM	Cosmos Health Enters the Development Phase for CCX0722, an Innovative Product for Obesity and Weight Management (ACCESSWIRE) +33.19%
Nov-21-22 07:00AM	Cosmos Health to Sell its Sky Premium Life Luxury Food Supplement Brand on Iberian Airlines' In-flight Magazine, Ronda. (ACCESSWIRE) +21.16%
Nov-17-22 01:15PM	Cosmos Health Requests Appeal from the Nasdaq Stock Market (ACCESSWIRE) +5.73%
Nov-15-22 11:05AM	Cosmos Health Reports Third Quarter 2022 Financial Results (ACCESSWIRE) -17.57%
Nov-14-22 09:00AM	Cosmos Health Obtains Exclusive Rights to Market and Distribute Nickelodeon's SpongeBob and PAW Patrol Kids' Vitamins in Greece and Cyprus (ACCESSWIRE) +20.33%
Oct-27-22 09:50AM	Cosmos Health and Smart for Life Execute Letter of Intent for Strategic Global Co-Venture (GlobeNewswire) -15.59%
Oct-18-22 08:00AM	Cosmos Health Announces Pricing of $7.5 Million Upsized Public Offering (ACCESSWIRE) -47.33%
Oct-04-22 09:00AM	Cosmos Health Enters into a Warrant Exchange Agreement, Replacing Structured Warrants with Plain-Vanilla Warrants (ACCESSWIRE)
Sep-28-22 09:00AM	Cosmos Health Enters into Letter of Intent for the Acquisition of ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp. (ACCESSWIRE)
Sep-22-22 09:20AM	Cosmos Health Signs an Agreement with Virax Biolabs to Distribute Monkeypox Virus Real-Time PCR Detections Kits in Europe (ACCESSWIRE) +10.83%
07:30AM	Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc. (PR Newswire)
Sep-15-22 09:15AM	Cosmos Health to Launch Sky Premium Life Nutritional Supplement Products in Germany and Austria via Amazon and Ebay (ACCESSWIRE)
Aug-25-22 09:25AM	Cosmos Health Launches First Sky Premium Life Nutritional Supplement Products on Amazon in the United States (ACCESSWIRE) +6.91%
Aug-22-22 09:15AM	Cosmos Health Reports 202.42 % Increase in Adjusted EBITDA and Positive Operating Income for the First Half of 2022 (ACCESSWIRE) +8.70%
Jul-29-22 09:15AM	Cosmos Holdings Announces Name Change to Cosmos Health, Reflecting Company's Evolution into an Innovative Global Healthcare Group, Driven by One Purpose: Improving People's Lives (ACCESSWIRE)
Jul-22-22 09:15AM	Cosmos Holdings Appoints Dr. Manfred Ziegler to its Advisory Board (ACCESSWIRE)
Jul-20-22 09:15AM	Cosmos Holdings Announces Agreement to Acquire Cana Laboratories, a Legacy European Pharmaceutical Company Established in 1928; Vertically Integrating its Manufacturing and R&D Capabilities and Expanding its Product Pipeline with New Brands (ACCESSWIRE) -9.96%
Jul-12-22 09:15AM	Cosmos Holdings Subsidiary Granted Full Membership in PAGB, A UK-based Consumer Healthcare Association (ACCESSWIRE) +7.02%
Jul-08-22 09:15AM	Cosmos Holdings Appoints Dr. Panagiotis Zoumpoulakis to its Advisory Board (ACCESSWIRE)
Jul-06-22 09:15AM	Cosmos Holdings to Acquire LIFE NLB Portfolio of Bone Health Products that Target the Gastrointestinal Microbiome (ACCESSWIRE) +5.19%
Jun-30-22 08:30AM	Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders (ACCESSWIRE)
Jun-02-22 09:00AM	Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon in the United States (ACCESSWIRE)
May-24-22 07:00AM	CEO Presenting on the Emerging Growth Conference on May 25 Register Now (GlobeNewswire) -6.25%
May-18-22 08:30AM	Cosmos Holdings Reports 12.5% Increase in Revenue, 88.9% Increase in Gross Profit and Achieves Profitability for the First Quarter of 2022 (ACCESSWIRE) +11.13%
May-05-22 09:15AM	Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon Canada (ACCESSWIRE)
May-03-22 09:15AM	Cosmos Holdings Appoints Finance Veteran Dr. Anastasios Aslidis to the Board of Directors and as a Member of the Board's Audit Committee (ACCESSWIRE) +12.77%
Apr-19-22 09:15AM	Cosmos Holdings Reports Continued Revenue Growth and Achieves $3.3 Million of Adjusted EBITDA for the Fiscal Year 2021 (ACCESSWIRE)
Apr-12-22 09:15AM	Cosmos Holdings Launches Mediterranation, a New Premium Nutritional Supplements Line (ACCESSWIRE) -16.67%
Apr-05-22 09:15AM	Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon Singapore (ACCESSWIRE)
Mar-31-22 09:00AM	Cosmos Holdings Launches Proprietary Sky Premium Life Brainlit Supplement for Brain Health (ACCESSWIRE)
Mar-28-22 09:00AM	Cosmos Holdings Launches Proprietary Sky Premium Life Prostatium Supplement for Prostate Health (ACCESSWIRE) -7.56%
Mar-24-22 09:00AM	Cosmos Holdings to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest (ACCESSWIRE)
Mar-23-22 09:25AM	Cosmos Holdings CEO Provides Letter to Shareholders (ACCESSWIRE) -5.56%
Mar-11-22 08:30AM	Cosmos Holdings to Ring Closing Bell Today to Celebrate Milestone NASDAQ Listing (ACCESSWIRE)
Mar-02-22 08:10AM	Cosmos Holdings Inc. (NASDAQ:COSM) insiders placed bullish bets worth US$6.0m in the last 12 months (Simply Wall St.)
Mar-01-22 08:00AM	Exchange Listing Client Cosmos Holdings, Inc. Approved to Trade on Nasdaq (GlobeNewswire)

Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. It is also involved in the research and development of its business units, and acquisition of pharmaceutical companies. The firm offers over-the-counter drugs, branded and generic medicines, and dietary and vitamin supplements. The company was founded on July 21, 2009 and is headquartered in Thessaloniki, Greece.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Siokas Grigorios	Chief Executive Officer	Oct 12	Buy	23.66	6,712	158,806	1,334,597	Oct 12 09:43 AM
Siokas Grigorios	Chief Executive Officer	Jul 20	Buy	2.48	181,451	449,998	1,327,885	Jul 24 11:44 AM
Siokas Grigorios	Chief Executive Officer	Jun 06	Buy	23.92	4,474	107,018	1,146,434	Jun 07 01:27 PM
Siokas Grigorios	Chief Executive Officer	Apr 27	Buy	24.64	4,474	110,239	1,141,960	Apr 28 09:27 AM
Siokas Grigorios	Chief Executive Officer	Apr 21	Buy	24.49	4,474	109,568	1,137,486	Apr 21 02:08 PM
Siokas Grigorios	Chief Executive Officer	Apr 07	Buy	24.37	2,238	54,540	1,133,012	Apr 10 01:02 PM
Siokas Grigorios	Chief Executive Officer	Dec 19	Buy	11.50	260,870	3,000,005	1,130,774	Dec 21 04:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

COSM

Cosmos Health Inc

Upgrade your FINVIZ experience